Affinia Therapeutics Alternatives & Competitors
12 companies similar to Affinia Therapeutics — Building the next generation of gene therapies
Companies similar to Affinia Therapeutics
Taysha Gene Therapies
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...
Dallas, United States
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
United Kingdom
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
Track all Affinia Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Arbor Biotechnologies
Genetic medicines for genetic diseases
Cambridge, United States
克睿基因 Cure Genetics
Benifiting Lives with Genetic Engineering
China
Code Biotherapeutics
Pioneering targeted delivery of precision genetic medicines
United States
StrideBio, Inc
The next evolution in gene therapy
Durham, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Apic Bio
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Anti...
Homology Medicines
Dedicated to addressing the root cause of rare genetic diseases and promising hope for pat...
GenEdit
Delivering the potential of genetic medicines
South San Francisco, Unit...
About Affinia Therapeutics
Affinia Therapeutics, founded in 2019, is at the forefront of biotechnology, focusing on building the next generation of gene therapies. This United States-based company boasts a team with extensive experience in translating scientific discoveries into clinical realities, targeting the genetic roots of severe, rare, an...
Development of gene therapies, Clinical trials for BAG3 DCM, AAV-based therapeutic solutions, Research and development in genetic diseases
Patients with rare genetic diseases, Healthcare providers specializing in cardiology and neurology, Research institutions focused on genetic medicine, Biotechnology investors
Gene Therapy, AAV9 Delivery, Genetic Medicines, Rare Diseases, Central Nervous System Diseases, Muscle Diseases, Synthetic Biology, Systems Biology, High-throughput Screening, Capsid Engineering, Heart Disease Treatment, Innovative Vector Design, Therapeutic Genetic Payload, Rational Design
B2B, B2D, Platform
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Affinia Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Affinia Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
